Malaria Journal

official impact factor 3.49

Open Access

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa

Christian T Happi*, Grace O Gbotosho, Onikepe A Folarin, Danny Milner, Ousmane Sarr, Akintunde Sowunmi, Dennis E Kyle, Wilbur K Milhous, Dyann F Wirth and Ayoade MJ Oduola

Malaria Journal 2006, 5:82 doi:10.1186/1475-2875-5-82

Accesses  

  • Last 30 days: 29 accesses
  • Last year: 330 accesses
  • All time: 3060 accesses

Cited by

BioMed Central: 3 citations

Research   Open Access

Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil

Colin J Sutherland, Matt Laundy, Nicholas Price, Martina Burke, Quinton L Fivelman, Geoffrey Pasvol, John L Klein, Peter L Chiodini Malaria Journal 2008, 7:240 (20 November 2008)

New evidence on role of mutations in malaria parasite cytochrome gene in cases of atovaquone resistance

Research   Open Access

In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand

Rommanee Khositnithikul, Peerapan Tan-ariya, Mathirut Mungthin Malaria Journal 2008, 7:23 (28 January 2008)

The absence of cross-resistance between atovaquone and most available drugs in 83 isolates suggests that AP could be used as an alternative antimalarial drug in Thailand.

Research   Open Access Highly Accessed

Sequence analysis of Plasmodium falciparum cytochrome b in multiple geographic sites

Marie-Thérèse Ekala, Nimol Khim, Eric Legrand, Milijaona Randrianarivelojosia, Ronan Jambou, Thierry Fandeur, Didier Menard, Serge-Brice Assi, Marie-Claire Henry, Christophe Rogier, Christiane Bouchier, Odile Mercereau-Puijalon Malaria Journal 2007, 6:164 (17 December 2007)

A study of sequence variation of Plasmodium falciparum cytochrome b from various locations on three continents discussing possible relevance to clinical failure